会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 줄기세포의 인 비보(in vivo) 이동 유도방법
    • 用于将干细胞移送到目标站的VIVO诱导方法
    • KR1020130124264A
    • 2013-11-13
    • KR1020130126071
    • 2013-10-22
    • 테고사이언스 (주)
    • 이진우박민성김윤희
    • A61K38/20A61K38/18A61K47/48A61K47/30
    • A61K38/2053A61K38/195A61L27/54A61L27/56A61L27/58A61L2300/252A61L2300/412A61L2430/24C07K14/523C07K14/5421C07K17/02A61K38/20A61K38/18A61K47/30A61K47/50
    • The present invention relates to an implantable composition for treating a damaged tissue and a method for inducing an in vivo migration of a cell for treatment to a damaged tissue region. According to the presen invention, a biodegradable scaffold reacted with chemotactic factors (for example, IL-8 or MIP-3α) of the present invention is implanted to a damaged location (for example, joint cartilage or skin) such that the damaged tissue can be treated by inducing/promoting homing of a cell for tissue generation. Thus, the composition of the present invention can not only be applied to the treatment of a damaged bone tissue, a joint cartilage, or a skin tissue more easily and efficiently compared to the conventional technologies, but also be used as a useful treatment supplement agent by enabling efficient utilization of cell resources for treatment, wherein the cell resources are high in scarcity in cell treatment using an allogeneic cell.
    • 本发明涉及一种用于治疗受损组织的可植入组合物和一种用于诱导用于治疗的细胞体内迁移至受损组织区域的方法。 根据本发明,将与本发明的趋化因子(例如,IL-8或MIP-3α)反应的可生物降解的支架植入损伤部位(例如关节软骨或皮肤),使得受损组织 可以通过诱导/促进细胞的归巢来治疗组织产生。 因此,与常规技术相比,本发明的组合物不仅可以用于治疗损伤的骨组织,关节软骨或皮肤组织,而且还可以用作有用的治疗补充剂 通过能够有效利用用于治疗的细胞资源,其中细胞资源在使用同种异体细胞的细胞处理中的稀缺性很高。